Tretinoin NDC 69238-2323

NDC codes

FDA NDC Directory

Product NDC (as listed)69238-2323Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69238-2323Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69238-2323-1	69238232301	1 BOTTLE, PUMP in 1 CARTON (69238-2323-1) / 50 g in 1 BOTTLE, PUMPMarketed from May 15, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tretinoin
Generic name (nonproprietary): tretinoin
Active ingredients: Tretinoin — .8 mg/g
Dosage form: Gel
Route: Topical
Labeler: Amneal Pharmaceuticals NY LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217497
Marketing start: May 15, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Retinoids (Chemical structure)
Identifiers: Product ID 69238-2323_4d764131-27ac-47d1-971b-849368e94e6fSPL ID 4d764131-27ac-47d1-971b-849368e94e6fSPL set ID 4b6006e3-f7a4-4823-8217-3e5b0f7e58d9RxCUI 1488045UNII 5688UTC01RUPC 0369238232318
Pharmacologic class: Retinoid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469238232301 followed by a unit qualifier and the quantity

Package 69238-2323-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 29, 2026.

Indications (excerpt from the label)

Tretinoin gel (microsphere) is indicated for the topical treatment of acne vulgaris in adults and pediatric patients 12 years of age and older. Tretinoin gel (microsphere)is a retinoid indicated for the topical treatment of acne vulgaris in adults and pediatric patients 12 years of age and older. (1)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)